Exemestane as primary treatment of oestrogen receptor-positive breast cancer in postmenopausal women: a phase II trial

Por Barnadas, A, Gil, M, González, S, Tusquets, I, Muñoz, M, Arcusa, A, Prieto, L, Margelí-Vila, M, Moreno, A
Publicado em 2009

Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy

Por Paré, L, Marcuello, E, Altés, A, Río, E del, Sedano, L, Salazar, J, Cortés, A, Barnadas, A, Baiget, M
Publicado em 2008

Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy

Por Paré, L, Marcuello, E, Altés, A, del Río, E, Sedano, L, Salazar, J, Cortés, A, Barnadas, A, Baiget, M
Publicado em 2009

Recommendations for the follow-up care of female breast cancer survivors: a guideline of the Spanish Society of Medical Oncology (SEOM), Spanish Society of General Medicine (SEMERG...

Por Barnadas, A., Algara, M., Cordoba, O., Casas, A., Gonzalez, M., Marzo, M., Montero, A., Muñoz, M., Ruiz, A., Santolaya, F., Fernandez, T.
Publicado no Clin Transl Oncol (2017)

Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas

Por Gallardo, A, Lerma, E, Escuin, D, Tibau, A, Muñoz, J, Ojeda, B, Barnadas, A, Adrover, E, Sánchez-Tejada, L, Giner, D, Ortiz-Martínez, F, Peiró, G
Publicado em 2012

Prescription refill, patient self-report and physician report in assessing adherence to oral endocrine therapy in early breast cancer patients: a retrospective cohort study in Cata...

Por Font, R, Espinas, J A, Gil-Gil, M, Barnadas, A, Ojeda, B, Tusquets, I, Segui, M A, Margelí, M, Arcusa, A, Prat, A, Garcia, M, Borras, J M
Publicado em 2012

Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry

Por Gallego, Oscar, Cuatrecasas, M., Benavides, M., Segura, P. P., Berrocal, A., Erill, N., Colomer, A., Quintana, M. J., Balaña, C., Gil, M., Gallardo, A., Murata, P., Barnadas, A.
Publicado em 2013

Erratum to: Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry

Por Gallego, Oscar, Cuatrecasas, M., Benavides, M., Segura, P. P., Berrocal, A., Erill, N., Colomer, A., Quintana, M. J., Balaña, C., Gil, M., Gallardo, A., Murata, P., Barnadas, A.
Publicado no J Neurooncol (2014)

Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma

Por Peiró, G, Ortiz-Martínez, F, Gallardo, A, Pérez-Balaguer, A, Sánchez-Payá, J, Ponce, J J, Tibau, A, López-Vilaro, L, Escuin, D, Adrover, E, Barnadas, A, Lerma, E
Publicado em 2014

Letrozole efficacy is related to human aromatase CYP19 single nucleotide polymorphisms (SNPs) in metastatic breast cancer

Por Colomer, R, Monzo, M, Tusquets, I, Rifa, J, Baena, JM, Barnadas, A, Calvo, L, Carabantes, F, Crespo, C, Muñoz, M, Llombart, A, Plazaola, A, Alba, E, Fuster, D, Gilabert, M, Lloveras, B
Publicado no Breast Cancer Res (2005)

Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial

Por Alba, E, Albanell, J, de la Haba, J, Barnadas, A, Calvo, L, Sánchez-Rovira, P, Ramos, M, Rojo, F, Burgués, O, Carrasco, E, Caballero, R, Porras, I, Tibau, A, Cámara, M C, Lluch, A
Publicado em 2014

Preventive treatments for breast cancer: recent developments

Por Alés-Martínez, J. E., Ruiz, A., Chacón, J. I., Lluch Hernández, A., Ramos, M., Córdoba, O., Aguirre, E., Barnadas, A., Jara, C., González, S., Plazaola, A., Florián, J., Andrés, R., Sánchez Rovira, P., Frau, A.
Publicado no Clin Transl Oncol (2014)